Immunophotodetection of Human Colon Cancer by ICCD Camera
ICCD 相机对人类结肠癌的免疫光电检测
基本信息
- 批准号:09671296
- 负责人:
- 金额:$ 1.98万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:1997
- 资助国家:日本
- 起止时间:1997 至 1998
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
PBS, Ig G labeled with FITC, or monoclonal antibody labeled with FITC were injected i.v. into nude mice bearing s.c. xenografts of human colon carcinoma TK15. Fluorescent intensity of tumor tissue in the control and Mab group were 480.5 and 848.4 at 24 hr after injection, and decreased at 48 hr after injection. Fluorescent dye : indocyanin Cy5.5 has an advantage over fluorescein in that it emits a more penetrating fluorescent red signal at 690 nm after excitation with a laser ray of 635 nm. PBS, Ig G labeled with Cy5.5, or Mab CEA labeled with Cy5.5 were injected i.v. into nude mice bearing S.C.Xenografts of human colon carcinoma TK4. Their fluorescence were observed by ICCD camera system. Fluorescent intensity of tumor tissue in control, IgG, and Mab group were 11, 25, and 44 at 24 hr after injection. Fluorescent intensity in Mab group increased significantly than the other groups. Para-aorta and inguinal lymph nodes of mice bearing i.p. xenograft of TK4 were observed by ICCD camera at 24 hr after injection Mab CEA labeled with Cy5.5 i.v.. fluorescence of metastatic lymph node was observed clearly. Such a demonstration opens the way to a new form of clinical imnmunophotodiagnosis in colon carcinoma.
静脉注射PBS、FITC标记的Ig G或FITC标记的单克隆抗体。进入携带皮下注射的裸鼠人结肠癌TK15的异种移植物。注射后24小时,对照组和Mab组肿瘤组织的荧光强度分别为480.5和848.4,注射后48小时下降。荧光染料:吲哚青素 Cy5.5 比荧光素的优势在于,在 635 nm 激光激发后,它在 690 nm 处发出更具穿透力的红色荧光信号。静脉注射PBS、Cy5.5标记的Ig G或Cy5.5标记的Mab CEA。进入携带人结肠癌TK4的S.C.异种移植物的裸鼠中。通过ICCD相机系统观察它们的荧光。注射后24小时,对照、IgG和Mab组肿瘤组织的荧光强度分别为11、25和44。 Mab组的荧光强度明显高于其他组。腹腔注射小鼠的主动脉旁和腹股沟淋巴结静脉注射Cy5.5标记的Mab CEA后24小时,通过ICCD相机观察TK4异种移植物,清楚地观察到转移淋巴结的荧光。这样的演示为结肠癌临床免疫光诊断的新形式开辟了道路。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
TANAKA Tatsuo其他文献
TANAKA Tatsuo的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('TANAKA Tatsuo', 18)}}的其他基金
Development of the new photodynamic therapy to intestinal cancer
新型光动力疗法治疗肠癌的进展
- 批准号:
19591537 - 财政年份:2007
- 资助金额:
$ 1.98万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Photodynamic therapy and diagnosis of5-aminolevulinic acid for gastrointestinal cancer
5-氨基乙酰丙酸治疗消化道肿瘤的光动力治疗及诊断
- 批准号:
16591309 - 财政年份:2004
- 资助金额:
$ 1.98万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Estimating network externalities and switching costs using individual users' data
使用单个用户的数据估计网络外部性和转换成本
- 批准号:
16330044 - 财政年份:2004
- 资助金额:
$ 1.98万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Anti-angiogenic Therapy on Gastrointestinal Cancer
胃肠癌的抗血管生成治疗
- 批准号:
11671225 - 财政年份:1999
- 资助金额:
$ 1.98万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Regulation of ribosomal protein gene expression in higher eukaryotes
高等真核生物核糖体蛋白基因表达的调控
- 批准号:
01570121 - 财政年份:1989
- 资助金额:
$ 1.98万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
The structure of ribosomal protein genes and the control mechanisms of their expression
核糖体蛋白基因的结构及其表达控制机制
- 批准号:
61570117 - 财政年份:1986
- 资助金额:
$ 1.98万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
相似国自然基金
核心蛋白聚糖(decorin)对大肠癌的抑制作用及分子机制研究
- 批准号:81001003
- 批准年份:2010
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Integrative Single-Cell Atlas of Host and Microenvironment in Colorectal Neoplastic Transformation
结直肠肿瘤转化中宿主和微环境的综合单细胞图谱
- 批准号:
10820067 - 财政年份:2023
- 资助金额:
$ 1.98万 - 项目类别:
Elucidating novel epigenetic modifications implicated in multiple myeloma risk disparities
阐明与多发性骨髓瘤风险差异相关的新型表观遗传修饰
- 批准号:
10912191 - 财政年份:2023
- 资助金额:
$ 1.98万 - 项目类别:
Understanding the full spectrum of epigenetic vulnerability in cancer through the delineation of DNA methylation function in gene 3' end
通过描绘基因 3 端 DNA 甲基化功能,全面了解癌症的表观遗传脆弱性
- 批准号:
10765365 - 财政年份:2023
- 资助金额:
$ 1.98万 - 项目类别:
Develop Conditionally Armored CAR Macrophage Therapy for Pancreatic Cancer
开发针对胰腺癌的条件装甲 CAR 巨噬细胞疗法
- 批准号:
10710883 - 财政年份:2023
- 资助金额:
$ 1.98万 - 项目类别: